No Data
No Data
Implied Volatility Surging for Haemonetics (HAE) Stock Options
Haemonetics Is Maintained at Neutral by Citigroup
Express News | Haemonetics Corp : Citigroup Cuts Target Price to $85 From $94
Citi Maintains Haemonetics(HAE.US) With Hold Rating, Cuts Target Price to $85
Top 3 Health Care Stocks That Are Set To Fly This Quarter
Haemonetics' Vascade MVP XL Vascular Closure System Enters US Market